Myriad Genetics, Inc. (MYGN)

5.87 -0.19 (-3.14%) USD  |  NASDAQ  |  Jan 23, 16:00
5.885 +0.02 (+0.26%) After-Hours: 20:00
More

Myriad Genetics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for MYGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Insulet Corp. Upgrade
Neogen Corp. Upgrade
ICU Medical, Inc. Upgrade
Intuitive Surgical, Inc. Upgrade
West Pharmaceutical Services, Inc. Upgrade